共 50 条
Update of D-dimer testing
被引:1
|作者:
Rosler, Alexander Eduard
[1
]
Orth, Matthias
[1
]
机构:
[1] Vinzenz von Paul Kliniken gGmbH, Inst Lab Med, D-70199 Stuttgart, Germany
来源:
关键词:
D-dimer;
fibrinolysis;
pulmonary embolism;
risk stratification;
thrombosis;
DEEP VENOUS THROMBOSIS;
DISSEMINATED INTRAVASCULAR COAGULATION;
SUSPECTED PULMONARY-EMBOLISM;
FIBRIN D-DIMER;
PLASMA D-DIMER;
VEIN THROMBOSIS;
CANCER-PATIENTS;
ANTICOAGULATION WITHDRAWAL;
DEGRADATION PRODUCTS;
CLINICAL PROBABILITY;
D O I:
10.1515/labmed-2011-0043
中图分类号:
R446 [实验室诊断];
R-33 [实验医学、医学实验];
学科分类号:
1001 ;
摘要:
D-dimer concentrations are elevated in a variety of clinical situations with hypercoagulability, such as venous thromboembolism (VTE), disseminated intravascular coagulation (DIC), ischemic cardiopathy, stroke, acute aortic dissection, malignomas, pregnancy, after surgery, traumas, and burns. D-dimer testing has become an essential tool for the diagnosis of VTE and pulmonary embolism because of its high negative predictive value, especially when used in conjunction with a clinical pretest score. D-dimer testing can be used for the diagnosis of DIC and other thrombotic diseases. It is also helpful for risk stratification in coronary artery disease, in first and recurrent thrombotic events, and for the timing of the duration of oral anticoagulation after a first episode of VTE. The use of D-dimer testing is limited in certain clinical conditions in which elevated D-dimer concentrations render the test unsuitable for the detection of acute thrombotic events.
引用
收藏
页码:65 / 75
页数:11
相关论文